Managing patients after cardiac transplantation.
To care for heart transplant recipients is to walk an endless tightrope, teetering between too little immunosuppression, and consequent rejection episodes, and too much immunosuppression, with its correlated infection and neoplasia risks. Moreover, as long-term survival has become a reality, accelerated coronary vascular disease poses a major threat to the transplanted organ.
Hunt
H A
HA
Division of Cardiology, Stanford University School of Medicine.
Schroeder
J S
JS
D000328:Adult; D000359:Aftercare / Q000379:methods*; D003324:Coronary Artery Disease / Q000139:chemically induced; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D006331:Heart Diseases / Q000175:diagnosis / Q000601:surgery; D016027:Heart Transplantation / Q000401:mortality; D006801:Humans; D007239:Infections / Q000276:immunology; D008232:Lymphoproliferative Disorders / Q000139:chemically induced; D008875:Middle Aged; D011379:Prognosis
D003524:Cyclosporins